StockData
Scilex Holding Co logo

Scilex Holding Co (SCLXW) stock

SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$0.04−0.00 (-1.53%)

Close on Oct 30, 2026Market cap $17.50MP/E –Yield –

Earnings

Scilex's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
Issued
Dec 1, 2023 · 2 items

Quarterly results

Revenue and earnings per share from each of Scilex's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2024ended Sep 30, 2024Oct 8, 2024during market hours–––Release
Q2 FY2024ended Jun 30, 2024Aug 1, 2024before the open–––Release
Q1 FY2024ended Mar 31, 2024Apr 16, 2024during market hours–––Release
Q4 FY2023ended Dec 31, 2023Mar 5, 2024during market hours–––Release
Q3 FY2023ended Sep 30, 2023Nov 1, 2023before the open–––Filing
Q2 FY2023ended Jun 30, 2023Jul 5, 2023before the open–––Filing
Q1 FY2023ended Mar 31, 2023Apr 3, 2023before the open–––Filing
Q4 FY2022ended Dec 31, 2022Feb 2, 2023before the open–––Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

No open guidance: every period Scilex guided for has been reported

Guidance history

Every forecast Scilex put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Dec 1, 2023gross sales for ZTlidoFY2023$140.00M – $150.00MNew
Dec 1, 2023net sales for ZTlidoFY2023$44.00M – $50.00MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Scilex filed with the SEC as exhibits to Form 8-K or 6-K

  1. Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
    Update
  2. Dear Scilex Holding Company Stockholders and other holders of Scilex Holding Company Securities:
    News
  3. Form of Scilex Holding Company Opt-In Agreement
    News
  4. Onboarding Documentation - Datavault AI Wallet Creation
    News
  5. Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
    Update
  6. 8-K exhibit EX-99.1
    Update
  7. Daniel A. Saunders (SBN 161051)
    Update
  8. Scilex Holding Company Announces Closing of Previously Announced Second Tranche Investment in Datavault AI Inc., Completing
    Update
  9. 8-K exhibit EX-99.1
    Update
  10. Scilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AI
    Update
  11. Scilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AI
    Update
  12. 8-K exhibit EX-99.1
    Update
  13. Capitalized terms used but not otherwise defined in this Exhibit 99.2, shall have their respective meanings as set forth in the Form 8-K to which this Exhibit is attached.
    Update
  14. For more information on Scilex Holding Company, refer to www.scilexholding.com
    Update
  15. Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
    News